Bridgebio Pharma Inc. (bbio 1.75 03/01/31)
13F holders, Q1 2026 (March 31)4holders
$4.09avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Bridgebio Pharma Inc. (bbio 1.75 03/01/31) in their 13F filings. The largest holders were Diadema Partners LP ($18.6M), Ssi Investment Management LLC ($7.0M) and State of Wisconsin Investment Board ($5.1M).
- Company
- Bridgebio Pharma Inc. (bbio 1.75 03/01/31)
- CUSIP
- 10806XAJ1
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $31.0M |
| Exits | 0 | $0 |
Ownership 4 holders
| Diadema Partners LP | 7.67% | New | 250,000 | $18.6M |
| Ssi Investment Management LLC | 0.58% | New | 4,134,000 | $7.0M |
| State of Wisconsin Investment Board | 0.01% | New | 3,000,000 | $5.1M |
| Bank of New York Mellon Corp | 0.00% | New | 200,000 | $340K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 1.75 03/01/31)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 1.75 03/01/31) the manager owns.